RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178.8 USD | +0.70% |
|
-3.77% | +3.97% |
| Apr. 17 | Wall St set for higher open on megacaps boost; earnings, Fed comments on tap | RE |
| Apr. 01 | Needham Adjusts ResMed's Price Target to $224 From $180, Maintains Buy Rating | MT |
Presenter SpeechSean Laaman (Analysts)Good morning, everybody. I'm Sean Laaman, the Australian...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-04-25
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
177.6
USD
Average target price
206.1
USD
Spread / Average Target
+16.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.97% | 26.09B | |
| +2.64% | 207B | |
| +1.80% | 175B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 08
